Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can group therapy for anxiety be as good as One-on-One sessions?

NCT ID NCT07579897

Symptom relief Sponsor: Sorlandet Hospital HF Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether group metacognitive therapy works as well as individual therapy for people with generalized anxiety disorder. 64 adults will be randomly assigned to either 10 weekly group sessions or 10 weekly individual sessions. The goal is to see if the group format can provide similar relief from anxiety, which could make treatment more available and cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
metacognitive therapy (a type of talk therapy that changes how you think about worrying)
What this could lead to
If group therapy works as well as individual sessions, it could make effective anxiety treatment more accessible and affordable for more people.
What could go wrong
This is a small, early-stage trial with only 64 people, so results may not apply to everyone. Group therapy might be less effective for some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults with a primary diagnosis of generalized anxiety disorder (GAD). GAD-7 score ≥ 10 at screening/baseline. Participants must endorse that they experience problems with excessive worry Exclusion Criteria: 1. Bipolar disorder; 2. Psychosis; 3. Ongoing substance abuse/dependence; 4. Intellectual disability based on previous medical history; 5. Eating disorder in need of medical attention; 6. Unwillingness to refrain from anxiolytic drugs during the treatment; 7. Current suicidal ideation with plan and intent; 8. Taking an unstable dose of antidepressant, with recent dose-change within the last 4 weeks; 9. Known cluster A or B personality disorder; 10. Serious medical comorbidity (e.g.: cancer, severe renal failure) 11. Language difficulties in need of an interpreter.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Generalized anxiety disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder generalized anxiety disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Generalized anxiety disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sørlandet Hospital HF

    RECRUITING

    Kristiansand, Agder, Norway

  • Sørlandet Hospital HF

    RECRUITING

    Kristiansand, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.